|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cost of revenues | ||||
| Gross profit | ||||
| Research and development expenses, net | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Other expenses (income), net | ||||
| Operating loss | ||||
| Finance income | ||||
| Finance expenses | ||||
| Loss before taxes on income | ||||
| Taxes on income (tax benefit) | ||||
| Loss from continuing operation | ||||
| Net income (loss) from discontinued operation | ||||
| Attributable to: | ||||
| Equity holders of the Company | ||||
| Non-controlling interests | ||||
| Profit (loss) | ||||
| Profit (loss) | ||||
| Basic loss per share from continuing operation (in Dollars per share) | ||||
| Diluted loss per share from continuing operation (in Dollars per share) (in Dollars per share) | ||||
| Basic loss per share from discontinued operation (in Dollars per share) | ||||
| Diluted loss per share from discontinued operation (in Dollars per share) (in Dollars per share) | ||||
| Weighted average number of shares outstanding used in computation of basic loss per share (in Shares) | ||||
| Weighted average number of shares outstanding used in computation of Diluted loss per share (in Shares) (in Shares) | ||||
Loading...
